BioNTech SE - ADR vs NetApp Inc. — how do they compare? BioNTech SE - ADR trades at $92.23 (market cap $23.31B), while NetApp Inc. trades at $199.79 (market cap $38.95B). The key difference: NetApp Inc. is the larger of the two by market cap, and NetApp Inc. pays a 1.05% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | NTAP | |
|---|---|---|
Market Cap | $23.31B | $38.95B |
Sector | Health | Technology |
52-Week High | $119.34 | $198.72 |
52-Week Low | $83.89 | $94.11 |
Enterprise Value | $6.60B | $38.10B |
Dividend Yield | — | 1.05% |
Trailing returns across standard periods
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →NetApp is a leading provider of enterprise data management and storage solutions. The company's three operating business units are products, software maintenance, and hardware maintenance. NetApp transitioned from a data center storage firm to a company with software data management solutions for multicloud environments. The California-headquartered company sells globally and has approximately 10,000 employees.
Read more on NTAP →